Context Therapeutics Inc. · NASDAQ:CNTX
BlackRock, Inc. reported a 6.70% stake in Context Therapeutics Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 6.70% stake in Context Therapeutics Inc., 6,169,250 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 6,169,250
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.70% | 6,169,250 |
Source
Related
- Context Therapeutics Inc.
- BlackRock, Inc.
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G · Octagon Capital Advisors LP · May 14, 2026